Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21765917 | 0.91 | ALDH1A1 (0.41) | SERPINE1NAAACYP2C19HTTCYP19A1 | |
| SCHEMBL21765668 | 0.91 | ALDH1A1 (0.41) | SERPINE1NAAACYP2C19HTTCYP19A1 | |
| SCHEMBL23194328 | 0.87 | CYP19A1 (0.43) | SERPINE1NAAACYP2C19HTTCYP19A1 | |
| SCHEMBL2431445 | 0.86 | NAAA (0.50) | NAAACYP2C19HTTCYP19A1SMN1; SMN2 | |
| SCHEMBL14944752 | 0.86 | ALDH1A1 (0.39) | NAAACYP2C19ADORA1ALDH1A1TRPA1 | |
| SCHEMBL25946775 | 0.85 | ANPEP (0.36) | SERPINE1NAAACYP2C19HTTCYP19A1 | |
| SCHEMBL4954811 | 0.84 | CYP2C19 (0.53) | NAAACYP2C19HTTCYP19A1SMN1; SMN2 | |
| SCHEMBL633774 | 0.84 | CYP2C19 (0.53) | NAAACYP2C19HTTCYP19A1SMN1; SMN2 | |
| SCHEMBL21765678 | 0.81 | ALDH1A1 (0.44) | SERPINE1NAAACYP2C19HTTCYP19A1 | |
| SCHEMBL21883836 | 0.81 | ALDH1A1 (0.44) | SERPINE1NAAACYP2C19HTTCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179665-A1 | COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF | PARABILIS MEDICINES, INC. | 2021-06-17 | — | — | US | disclosed |
| WO-2020041270-A1 | COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179665-A1 | COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF | IAPP, VIP, NGLY1 | SERPINE1 591/4885NAAA 2005/4885CYP2C19 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.